Indobufen
![]() | |
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | B01AC10 (WHO) |
Identifiers | |
| |
CAS Number |
63610-08-2 ![]() |
PubChem (CID) | 107641 |
ChemSpider |
96823 ![]() |
UNII |
6T9949G4LZ ![]() |
KEGG |
D07141 ![]() |
ChEMBL |
CHEMBL1765292 ![]() |
ECHA InfoCard | 100.058.496 |
Chemical and physical data | |
Formula | C18H17NO3 |
Molar mass | 295.333 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
![]() ![]() |
Indobufen is a platelet aggregation inhibitor.[1] It acts as a reversible cyclooxygenase inhibitor.[2]
References
- ↑ The Merck Index, 12th Edition. 4991
- ↑ Eligini, Sonia; Violi, F; Banfi, C; Barbieri, SS; Brambilla, M; Saliola, M; Tremoli, E; Colli, S (2005). "Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism". Cardiovascular Research. 69 (1): 218–226. doi:10.1016/j.cardiores.2005.07.013. PMID 16154551.
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.